Bhekisisa Centre for Health Journalism’s Post

FDA Approved ❤️👇👇 Great Effort By India ❤️ Nafithromycin, the India’s first indigenous Macrolide antibiotic. As per reports, this groundbreaking antibiotic is ten times more effective than current treatments like azithromycin and offers a three-day treatment regimen, significantly shortening the recovery time while improving patient outcomes. Nafithromycin is designed to treat both typical and atypical drug-resistant bacteria, making it a crucial tool in addressing the global health crisis of AMR ~Anti-microbial Resistance~. #antibioticstewerdship #Innvention

Interesting to see what impact these findings will have on adherence rates, cost of healthcare and, of course, the reduced risk of antibiotic resistance...

This recent study co-authored by our Global Access Director Jennifer Cohn investigates the effect of shortages on health systems and patient outcomes With the lack of access to safe and effective antibiotics contributing to the emergence and spread of antimicrobial resistance (AMR), this study  highlights how economic viability and reliance on single-source ingredients are key drivers of antibiotic shortages. Read more about "A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages": https://lnkd.in/dshtJsPh

We conducted an in-depth trial to explore Lactifen's potential to improve calf health and reduce reliance on antimicrobials. The results speak volumes for the role Lactifen can play in supporting calf health and promoting more responsible antimicrobial use on the farm. Here’s what we found: ⤵️ About the Trial: • From days 4 to 10, calves received 6 grams of Lactifen daily. We also maintained a control group for comparison. • The calves provided Lactifen gained an extra 10 pounds on average and showed reduced rates of diarrhea. • Treatment needs decreased: calves on Lactifen saw a 22% reduction in non-steroidal anti-inflammatory drug use and a 17% drop in antimicrobial treatment needs. These promising results highlight Lactifen’s potential to support healthier, faster-growing calves with reduced dependence on medications. 📈 #bovineresearch #calfhealth #CdnAg, #AgResearch

Responsible use of antibiotics and proactive measures today will secure their effectiveness for tomorrow. Join the fight against AMR. #AMR #AntimicrobialResistance #AntibioticResistance #DDukaan #HealthAndWellness #ScotmannPharmaceuticals

The rising incidence of antibiotic resistance threatens a repeat of the pre-antibiotic era when it was difficult to treat common infections effectively. The problem is being worsened by antibiotic misuse and overuse, both of which facilitate the development of superbugs that existing drugs can't combat, risking millions of lives annually. Global action and awareness are crucial as we face a potential future where minor infections can be deadly. We must advocate for responsible antibiotic use, bolster healthcare access worldwide, and innovate new treatments. Our choices today will decide whether we preserve or lose a century of medical progress. Read more: https://lnkd.in/dzHxit9u

Five years on from its publication, When Antibiotics Fail remains a frequent, ongoing touchstone for understanding AMR's potential impacts in Canada. Explore our impact report https://lnkd.in/gyKw_Nx8

 🌎 It's World Antimicrobial Resistance Week 🌎   Antimicrobial resistance (AMR) has become one of the most pressing global health challenges of our time. The ability of microorganisms to resist the effects of medication has led to a significant increase in untreatable infections, posing a serious threat to public health and the effectiveness of modern medicine. 🦠 Over time, all antibiotics have lost effectiveness against their targeted bacteria. Antimicrobial resistance is increasingly recognized as a critical threat to global public health and economic stability. ⚕️ So, what can we do about it? 🤔 There are several strategies to mitigate the spread of AMR, including:  ✅ strengthening global surveillance systems  ✅promoting responsible use of antibiotics  ✅investing in research and development of new treatments  ✅enhancing international collaboration and policy frameworks  ✅improving access to effective treatments  ✅enforcing stricter regulations on antibiotic sales and usage TAXIS Pharmaceuticals, Inc. is developing therapies to combat by getting to the root cause of the issue, targeting the very foundation of bacterial survival. Find out more in our blog, “The Science Behind Superbugs: The Path to New Solutions in the Fight Against Antimicrobial Resistance”  https://bit.ly/4geejwk #WorldAMRAwarenessWeek #AMRawareness #antibiotics #health #pharma #superbugs #medicine #publichealth #AMR #pharmaceuticals #antimicrobialresistance #antibioticresistance #globalhealth #worldhealth #health #healthcare #medicine World Health Organization Centers for Disease Control and Prevention

You will likely see the phrase “antimicrobial resistance” (AMR) a lot this week as part of the WHO’s AMR Awareness Week. Do you wonder what it actually means? In short, AMR occurs when microorganisms grow resistant, making today’s medicines, such as antibiotics, ineffective. The main drivers of AMR are overuse and misuse of antimicrobials. As individuals, we can all help curb the spread of resistance. 👇 #WAAW #AntimicrobialResistance

Heard on Day 1 and Day 2 of the World Anti-Microbial Resistance Congress, there is always a need for a pipeline of antibiotics as resistance to antibiotics will always come. If we know the lifetime of an #antibiotic medication is limited as bacteria will always evolve and develop #resistance, why isn’t there a greater financial incentive for the development of new antibiotics? Shouldn’t the low shelf life mean limited #Supply? While the need (#Demand) grow as population and #AMR risk grows? #WorldAMRCongress #DiseasePreventionSummit #antimicrobialresistance #antimicrobial